Henry Schein, Inc.

NASDAQ:HSIC

Medical - Distribution

Healthcare
$85.69 -1.53%

-$1.24 today

Market cap
$9.47B
Beta
0.82
P/E (TTM)
23.3
EPS (TTM)
$3.44
52W Low $61.95High $89.29

Volume 2.08M

Average 1.39M

HSIC Income Before Tax

Profit after all operating and non-operating items but before income tax.

Henry Schein, Inc.NASDAQ: HSIC

Income Before Tax · Q2 FY2026 · quarter ended Jun 2026

Income before tax growth accelerates

Q2 FY2026 income before tax of $136M rose 8.8% year over year, ahead of the +5.1% change in trailing-twelve-month income before tax. Sequentially, it fell 9.3% from the prior quarter. Over 3 fiscal years it compounded at -9.5% a year.

Context

  • Income before tax amounted to 4.1% of revenue in FY2025, unchanged from a year earlier.
  • Income before tax increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +8.8% holds above the trailing-twelve-month pace of +5.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$136M-9.3% QoQ
Last fiscal yearDec 2025
$545M+3.6% YoY
LTMJun 2026
$558M+5.1% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.8%——
1 year+3.6%——
3-year CAGR-9.5%——
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
545M USD
Year-over-year change
+3.6%
4-year CAGR
-10.5%

Income Before Tax vs competitors

How HSIC compares with its peers on the latest reported figures

  • HSIC's LTM Jun 2026 income before tax of $558M is the 5th highest of the 7 companies compared; the peer median is $1.47B.
  • Its year-over-year change of +5.1% is the 6th highest of 7, against a peer median of +44.8%.
  • Income before tax amounts to 4.1% of revenue for HSIC, versus a peer median of 2.9%.
HSIC Competitors Peer median
Income Before Tax for HSIC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MCKMcKesson CorporationLTM Jun 2026$6.46B +49.3%+10.2%1.6%
CORCencora, Inc.LTM Jun 2026$3.61B +40.3%+1.1%1.1%
CAHCardinal Health, Inc.LTM Sep 2026$2.26B +4.9%+48.6%0.9%
NVSTEnvista Holdings CorpLTM Oct 2026$684.4M +338.4%-14.5%23.8%
HSICHenry Schein, Inc.LTM Jun 2026$558M +5.1%-9.5%4.1%
ACHAccendra Health, Inc.LTM Mar 2026-$112.8M +67.1%—4.2%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026-$572M +38.0%—15.5%
Peer median (excluding HSIC) $1.47B+44.8%+5.7%2.9%

Competitors are the stored peer set for HSIC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue12.4B12.65B12.34B12.67B13.18B
Cost of Revenue8.73B9B8.69B8.91B9.34B
Gross Profit3.67B3.65B3.65B3.77B3.84B
Gross Margin29.6%28.9%29.6%29.7%29.1%
Research & Development00000
Selling, General & Admin2.82B2.71B2.94B3.04B3.08B
Operating Expenses2.82B2.71B2.94B3.04B3.08B
Depreciation & Amortization209.53M212M222M268M311M
EBITDA1.07B977M851M912M1.01B
EBITDA Margin8.6%7.7%6.9%7.2%7.6%
Operating Income854.81M938M714M729M758M
Operating Margin6.9%7.4%5.8%5.8%5.7%
Interest Income6.45M17M17M24M33M
Interest Expense27.6M44M87M131M150M
Other Income / Expenses(4.25M)(202M)(158M)(203M)(213M)
Income Before Tax850.56M736M556M526M545M
Pre-Tax Margin6.9%5.8%4.5%4.2%4.1%
Income Tax Expense197.35M170M120M128M126M
Net Income623.91M538M416M390M398M
Net Margin5.0%4.3%3.4%3.1%3.0%
EPS (Basic)4.513.953.183.073.29
EPS (Diluted)4.453.913.163.053.27
Weighted Avg Shares140.09M136.06M130.62M126.79M120.81M
Weighted Avg Shares (Diluted)141.77M137.76M131.75M127.78M121.72M

Henry Schein, Inc.

NASDAQ:HSIC

Intrinsic Alpha fair value

Locked

Current Price

$85.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.